Page last updated: 2024-09-05

enzastaurin and Carcinoma, Transitional Cell

enzastaurin has been researched along with Carcinoma, Transitional Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jian, W; Lerner, SP; Levitt, JM; Sonpavde, G; Yamashita, H	1

Other Studies

1 other study(ies) available for enzastaurin and Carcinoma, Transitional Cell

Article	Year
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine. Molecular cancer therapeutics, 2009, Volume: 8, Issue:7 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoenzyme Techniques; Indoles; Mice; Mice, Nude; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Ribonucleotide Reductases	2009

Article

Year

Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine.

Molecular cancer therapeutics, 2009, Volume: 8, Issue:7

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoenzyme Techniques; Indoles; Mice; Mice, Nude; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Ribonucleotide Reductases

2009